Navigation Links
Prostate Cancer and Bone Health
Date:6/22/2012

NEW YORK, June 22, 2012 /PRNewswire/ -- When weighing prostate cancer treatment options, potential side effects such as urinary control and sexual potency are the hot buttons. Seldom discussed, though significantly more damaging, is bone disease. Early diagnosis of prostate cancer, and the right treatment path, can drastically reduce a man's risk of developing prostate cancer-related bone disease.

(Photo: http://photos.prnewswire.com/prnh/20120622/NY28935 )

World renowned prostate surgery and robotic surgeon, Dr. David Samadi, pushes for comprehensive patient education, "Men are largely unaware of how prostate cancer can affect their bones."

As reported in the Bone Health In Focus Prostate Cancer report, which aims to increase awareness of prostate cancer-related bone disease, only one third of prostate cancer patients claim to have discussed bone health and the risk of bone metastases with their physician. Shocking for a secondary disease that can significantly impair quality of life and ultimately decrease survival by more than three years.

Prostate cancer-related bone disease results from either:

1)    Cancer Treatment-Induced Bone Loss (CTIBL)

"Seldom are men made aware of the damaging affects of androgen deprivation therapy (ADT) on their bones," says Dr. Samadi. "Hormone therapy for prostate cancer is proven to significantly decrease bone mass and cause bone weakening."

Also in the Bone Health In Focus Prostate Cancer report are statistics indicating less than half of men with non-metastatic prostate cancer were even aware that hormone therapy could damage their bones. One study found incidence of bone fracture in nearly one in five men within five years of beginning ADT.

"This lack of information can be seriously detrimental as a man weighs his prostate cancer treatment options," cautions Dr. Samadi. "Men who opt for hormone therapy may be further jeopardizing their health and their power to fight prostate cancer. Robotic prostatectomy surgery removes the cancerous prostate and significantly reduces the risk of metastases."

2)    Bone Metastases

Prostate cancer is an unpredictable disease and can spread quickly, without warning and without symptoms. Men who skip their annual PSA blood test are putting themselves at risk for late-stage diagnosis. Others may be diagnosed early, but choose not to treat their prostate cancer, opting instead for watchful waiting.

"Delaying diagnosis or treatment of prostate cancer opens the door to bone disease and unnecessarily exposes men to another life-threatening condition," cautions Dr. Samadi. Bone disease skeletal-related events (SREs) such as fracture or spinal cord injury are serious alone, but they can also interfere with a man's prostate cancer treatment.

"Unfortunately, many men are unaware that late-stage diagnosis of prostate cancer has implications beyond the cancer itself," Dr. Samadi explains. "Prostate cancer-related bone disease is further evidence of the irresponsible nature of the U.S. government task force's recommendation against the PSA test."

Roughly 75 percent of men diagnosed with an advanced form of prostate cancer will develop bone metastases.

"Men don't have to fear bone disease, but they do have to be knowledgeable about it," says Dr. Samadi. "It is not inevitable. Early diagnosis beginning with the PSA test and swift treatment through robotic prostate removal surgery can help eliminate prostate cancer long before the bones are affected."

Dr. David Samadi is Vice Chairman of the Department of Urology and Chief of Robotics and Minimally Invasive Surgery at Mount Sinai Medical Center, and creator of the SMART (Samadi Modified Advanced Robotic Technique) robotic prostatectomy surgery.

Related Links:

http://www.smart-surgery.com/
http://il.smart-surgery.com/
http://www.roboticoncology.com
http://www.roboticoncology-il.com/

 


'/>"/>
SOURCE smart-surgery.com
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. New Research Reveals Some Natural Supplements Effective Against Prostate Cancer
2. Breakthrough Prostate Cancer Diagnostics
3. Arkansas Prostate Cancer Center Earns High Honor of ACR-ASTRO Accreditation
4. CyberKnife® Prostate SBRT Outcomes and Quality of Life Data Presented at American Urological Association Meeting
5. Ventana licenses Gen-Probe IP for measuring ERG protein in prostate cancer patients
6. US HIFU to Showcase High Intensity Focused Ultrasound for the Treatment of Prostate Cancer at AUA
7. Debiopharm and Vifor Pharma Sign an Exclusive Agreement for the Distribution and Commercialization of Pamorelin®LA in Switzerland - A Drug Treatment for Prostate Cancer and Endometriosis
8. Accuray Launches First Study to Compare CyberKnife® SBRT to Surgery and IMRT for Treatment of Early-Stage Prostate Cancer
9. New Veridex Alliance Drives Study Of Circulating Tumor Cells In Men With Metastatic Prostate Cancer
10. New Candidate Drug Stops Cancer Cells, Regenerates Nerve Cells
11. Austrian Medical Center Upgrades Cancer Treatment System, Improves Patient Care with Elektas Agility Beam-shaping Device
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... 22, 2017 Oncternal Therapeutics, Inc., a ... rare and common malignancies, today announced the closing ... company intends to use the proceeds to further ... to advance preclinical development of a new ROR1-targeted ... a first-in-class anti-ROR1 monoclonal antibody being developed to ...
(Date:2/22/2017)...  CVS Pharmacy is the first national retail pharmacy ... (PHO), the primary source of artificial trans fats in ... products. The retailer now offers over 600 exclusive snack ... fats. This comes a year and a half ahead of ... for processed foods to be reformulated without artificial trans ...
(Date:2/22/2017)... 2017 Des scanners sur smartphone destinés aux professionnels ... Europe , au Moyen-Orient et en Afrique  ... Clarius Mobile Health , une société de santé ... au Canada , a annoncé aujourd,hui qu,elle a reçu ... fil Clarius C3 et L7, destinés à être utilisés par des professionnels ...
Breaking Medicine Technology:
(Date:2/22/2017)... GA (PRWEB) , ... February 22, 2017 , ... Super-Sod ... 25 and 26 event in Athens, Georgia. , A shift from Super-Sod’s simple Athens ... in Georgia. , For the booth, grass seed plant manager Chris Roquemore constructed furniture ...
(Date:2/22/2017)... ... ... BrightStar Care Charleston , a home care and medical staffing agency, will ... on Aging’s Senior Expo on Thursday, March 23, 2017, at the Omar Convention ... our community. We are thrilled to participate in this event because we believe it ...
(Date:2/22/2017)... (PRWEB) , ... February 22, 2017 , ... ... solutions for supply chain management (SCM) and spend management, today announced that Keppel ... save time, and simplify expense tracking. , “We are excited to announce ...
(Date:2/21/2017)... ... February 21, 2017 , ... ... introduced five new hospital-grade power extension cords that meet the most current standards. ... the 2012 edition of the National Fire Protection Association (NFPA) 101 – Life ...
(Date:2/21/2017)... ... February 21, 2017 , ... Individuals who have been diagnosed ... surgery, treatment, therapy and management. Regular exercise in proper environments has been shown ... their diseases. On February 23, 2017, 1:00-2:00 p.m. E.S.T., a dynamic HydroWorx ...
Breaking Medicine News(10 mins):